Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Alastair Copland is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Interferon-γ and IL-27 positively regulate type 1 regulatory T-cell development during adaptive tolerance
Lecky, D., Sheriff, L., Rouvray, S., George, L. S., Copland, A., Drummond, R., Wraith, D. & Bending, D., 28 Mar 2025, (E-pub ahead of print) In: iScience. 112308.Research output: Contribution to journal › Article › peer-review
Open AccessFile39 Downloads (Pure) -
Lag3 and PD-1 pathways preferentially regulate NFAT-dependent TCR signalling programmes during early CD4+ T cell activation
Sheriff, L., Copland, A., Lecky, D., Done, R., George, L. S., Jennings, E., Rouvray, S., Elliot, T., Jinks, E., Pallan, L. & Bending, D., 11 May 2025, In: Immunotherapy Advances. 5, 1, 15 p., ltaf015.Research output: Contribution to journal › Article › peer-review
Open AccessFile69 Downloads (Pure) -
Preclinical Development of a Tolerogenic Peptide From Glutamate Decarboxylase as a Candidate for Antigen-Specific Immunotherapy in Type 1 Diabetes
Ng, S. T. H., Price, M. J., Richardson, N., Nawaf, M., Copland, A., Streeter, H. B., Narendran, P. & Wraith, D. C., 1 Mar 2025, In: Diabetes. 74, 3, p. 384-397 14 p.Research output: Contribution to journal › Article › peer-review
-
Lag3 and PD-L1 govern T cell receptor signal duration in adaptively tolerised CD4+ T cells
Sheriff, L., Copland, A., Lecky, D., Done, R., George, L. S., Jennings, E., Rouvray, S., Elliot, T., Jinks, E. S., Pallan, L. & Bending, D., 9 Jun 2024, bioRxiv.Research output: Working paper/Preprint › Preprint
-
Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity
Copland, A., Mackie, G. M., Scarfe, L., Jinks, E., Lecky, D. A. J., Gudgeon, N., McQuade, R., Ono, M., Barthel, M., Hardt, W.-D., Ohno, H., Hoevenaar, W. H. M., Dimeloe, S., Bending, D. & Maslowski, K. M., 18 Nov 2024, (E-pub ahead of print) In: EMBO Molecular Medicine.Research output: Contribution to journal › Article › peer-review
Open AccessFile123 Downloads (Pure)